Victoria, British Columbia Thursday, November 14, 2024, 18:00 Hrs [IST] ...

A common acid reflux medication taken by 15 per cent of the UK population could be contributing to a rise in scurvy cases, ...

One of three patients in Cohort 5 achieved complete histological remission at 12 weeks. <li /> Consistent improve ...

On whether the available data supported a clinical benefit, 13 of the 14 panelists said no. Intercept said it will work with ...

AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...

In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...

The investigational monoclonal antibody cendakimab significantly improved symptoms and reduced esophageal eosinophils in ...

New research is exploring low-cost, non-invasive ways to diagnose Barrett's esophagus, a condition associated with deadly esophageal cancer, to find effective strategies to identify patients with this ...

as a treatment of the chronic disease eosinophilic esophagitis. Data describing the pharmacokinetic profile, safety and tolerability of the drug candidate was evaluated between every dose escalation.

This unique approach offers a solution for men who prefer to avoid pills or are unable to take them due to health concerns, positioning Eddie as a standout option in the ED treatment market.